logo

For the Inventor, By the Inventor

Edingen-Neckarhausen, Germany

Thomas Hoger

This inventor holds 7 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 1997-2006.

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 59(Granted Patents)


Company Filing History:

goldMedal7 out of 10,754 
 
Basf Aktiengesellschaft
 patents

Years Active: 1997-2006

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7087637 - Substituted indoles which are PARP inhibitors (2006-08-08),
2. 6028073 - N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as (2000-02-22),
3. 5908844 - N-substituted azabicycloalkane derivatives, their preparation and use (1999-06-01),
4. 5756697 - Subunits of glutamate receptors, their preparation and their use (1998-05-26),
5. 5753690 - N-substituted azobicycloheptane derivatives, the preparation and use (1998-05-19),
6. 5703091 - N-substituted azabicycloalkane derivatives, their preparation and use (1997-12-30),
7. 5616705 - N-substituted azabicycloheptane derivatives, their preparation and use (1997-04-01),

Title: Thomas Hoger: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Hoger is a distinguished inventor based in Edingen-Neckarhausen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 7 patents to his name, Hoger's work has the potential to impact drug development and treatment options.

Latest Patents

Among his latest patents, Hoger has developed substituted indoles that act as PARP inhibitors. This invention relates to novel indole derivatives, their preparation, and their use as inhibitors of the enzyme poly(ADP-ribose)polymerase, or PARP (EC 2.4.2.30), for producing drugs. Additionally, he has worked on N-substituted 3-azabicyclo (3.2.0)heptane derivatives, which are also useful in pharmaceutical applications.

Career Highlights

Hoger is currently associated with BASF Aktiengesellschaft, a leading global chemical company. His role at BASF has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the company's portfolio of drug candidates.

Collaborations

Throughout his career, Hoger has collaborated with notable colleagues, including Gerd Steiner and Rainer Munschauer. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

In summary, Thomas Hoger is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative patents and collaborations highlight his commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…